TABLE 2.
Crude proportions of second‐line treatment prescribed by ethnicity or by deprivation
| Second‐line antidiabetic treatment prescribed | |||
|---|---|---|---|
| Variable of interest | Metformin‐SUs | Metformin‐DPP‐4 inhibitors | Metformin‐SGLT2 inhibitors |
| Ethnicity, n (row %) | |||
| White | 11 584 (37) | 13 398 (43) | 6455 (21) |
| South Asian | 1316 (37) | 1530 (44) | 667 (19) |
| Black | 593 (46) | 524 (40) | 179 (14) |
| Mixed/other | 216 (39) | 249 (45) | 93 (17) |
| IMD quintile, n (row %) | |||
| 1 (least deprived) | 2155 (37) | 2483 (42) | 1264 (21) |
| 2 | 2432 (37) | 2833 (43) | 1388 (21) |
| 3 | 2654 (37) | 2972 (42) | 1476 (21) |
| 4 | 3112 (38) | 3975 (44) | 1628 (20) |
| 5 (most deprived) | 3356 (37) | 3975 (44) | 1638 (18) |
Abbreviations: DPP‐4, dipeptidyl peptidase‐4; IMD, Index of Multiple Deprivation; SGLT2, sodium‐glucose cotransporter 2; SU, sulphonylurea.